Lok ASF - Search Results

1

Hepatitis B RNA and Core-Related Antigen Provide Value Beyond DNA in Evaluating e But Not Surface Antigen Clearance.

King WC, Sterling RK, Hinerman AS, Lok ASF, Cloherty GA, Ghany MG; HBRN HBV NOVELASSAYS GROUP. King WC, et al. Among authors: lok asf. Clin Gastroenterol Hepatol. 2023 Jul;21(7):1957-1959. doi: 10.1016/j.cgh.2022.06.019. Epub 2022 Jul 16. Clin Gastroenterol Hepatol. 2023. PMID: 35850413

2

Treatment of hepatitis B.

Wai CT, Lok AS. Wai CT, et al. J Gastroenterol. 2002;37(10):771-8. doi: 10.1007/s005350200129. J Gastroenterol. 2002. PMID: 12424559 Free article. Review.

3

Hepatitis B virus genotypes in the United States: results of a nationwide study.

Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, Carey W, Brown RS Jr, Luketic VA, Terrault N, Lok AS. Chu CJ, et al. Gastroenterology. 2003 Aug;125(2):444-51. doi: 10.1016/s0016-5085(03)00895-3. Gastroenterology. 2003. PMID: 12891547

4

Prevalence of HBV precore/core promoter variants in the United States.

Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, Carey W, Brown RS Jr, Luketic VA, Terrault N, Lok AS; U.S. HBV Epidemiology Study Group. Chu CJ, et al. Hepatology. 2003 Sep;38(3):619-28. doi: 10.1053/jhep.2003.50352. Hepatology. 2003. PMID: 12939588 Free article.

5

Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status.

Di Bisceglie AM, Lyra AC, Schwartz M, Reddy RK, Martin P, Gores G, Lok AS, Hussain KB, Gish R, Van Thiel DH, Younossi Z, Tong M, Hassanein T, Balart L, Fleckenstein J, Flamm S, Blei A, Befeler AS; Liver Cancer Network. Di Bisceglie AM, et al. Am J Gastroenterol. 2003 Sep;98(9):2060-3. doi: 10.1111/j.1572-0241.2003.t01-1-07641.x. Am J Gastroenterol. 2003. PMID: 14499788

6

Treatment of chronic hepatitis B: who to treat, what to use, and for how long?

Fung SK, Lok AS. Fung SK, et al. Clin Gastroenterol Hepatol. 2004 Oct;2(10):839-48. doi: 10.1016/s1542-3565(04)00386-6. Clin Gastroenterol Hepatol. 2004. PMID: 15476146 Review.

7

Clinical outcome and virological characteristics of hepatitis B-related acute liver failure in the United States.

Wai CT, Fontana RJ, Polson J, Hussain M, Shakil AO, Han SH, Davern TJ, Lee WM, Lok AS; US Acute Liver Failure Study Group. Wai CT, et al. J Viral Hepat. 2005 Mar;12(2):192-8. doi: 10.1111/j.1365-2893.2005.00581.x. J Viral Hepat. 2005. PMID: 15720535 Free article.

8

Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.

Lok AS, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, Everhart JE, Lindsay KL, Bonkovsky HL, Di Bisceglie AM, Lee WM, Morgan TR, Dienstag JL, Morishima C. Lok AS, et al. Hepatology. 2005 Aug;42(2):282-92. doi: 10.1002/hep.20772. Hepatology. 2005. PMID: 15986415 Free article.

9

Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.

Di Bisceglie AM, Sterling RK, Chung RT, Everhart JE, Dienstag JL, Bonkovsky HL, Wright EC, Everson GT, Lindsay KL, Lok AS, Lee WM, Morgan TR, Ghany MG, Gretch DR; HALT-C Trial Group. Di Bisceglie AM, et al. J Hepatol. 2005 Sep;43(3):434-41. doi: 10.1016/j.jhep.2005.03.019. J Hepatol. 2005. PMID: 16136646 Clinical Trial.

10

HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial.

Morishima C, Morgan TR, Everhart JE, Wright EC, Shiffman ML, Everson GT, Lindsay KL, Lok AS, Bonkovsky HL, Di Bisceglie AM, Lee WM, Dienstag JL, Ghany MG, Gretch DR; HALT-C Trial Group. Morishima C, et al. Hepatology. 2006 Aug;44(2):360-7. doi: 10.1002/hep.21265. Hepatology. 2006. PMID: 16871570 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

234 results

Search Page